Holly Springs, N.C.
The U.S. Department of Health and Human Services awarded Novartis a $486 million contract in early 2009 to build pandemic flu vaccine manufacturing facilities in Holly Springs, N.C. The funding will support the design, construction, and validation of flu vaccine production centers over the next eight years, enabling Novartis to supply 150 million doses of cell-based influenza vaccine within six months of the onset of a pandemic.
